ATAI
NASDAQ · Pharmaceuticals
Ataibeckley Inc
$4.22
+0.12 (+2.93%)
Open$4.10
Previous Close$4.10
Day High$4.24
Day Low$4.08
52W High$6.75
52W Low$2.00
Volume—
Avg Volume5.67M
Market Cap1.49B
P/E Ratio—
EPS$-2.23
SectorPharmaceuticals
Analyst Ratings
Strong Buy
20 analysts
Price Target
+858.3% upside
Current
$4.22
$4.22
Target
$40.44
$40.44
$27.58
$40.44 avg
$50.46
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 6.70M | 2.70M | 436.73M |
| Net Income | -1,078,037,771 | -1,191,899,115 | 64.85M |
| Profit Margin | -16,142.0% | -46,040.8% | 14.9% |
| EBITDA | -1,039,003,902 | -1,216,403,523 | 102.81M |
| Free Cash Flow | — | — | 81.44M |
| Rev Growth | +161.0% | -75.3% | -6.2% |
| Debt/Equity | — | 0.20 | 0.24 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |